Status:
COMPLETED
Prevalence of Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Children of 12-18 Months in 6 Cities, China
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Streptococcus Pneumoniae Infections
Eligibility:
All Genders
12-18 years
Brief Summary
This study is to observe the carriage rate of Streptococcus pneumoniae (S.p.), Haemophilus influenzae Type B (Hib) and Moraxella catarrhalis (M.Cat.) in healthy Chinese children aged 12-18 months in o...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Healthy children aged 12-18 months
- Exclusion Criteria
- Use of antibiotics up to 15 days prior to study inclusion
- Malformation or injury of the nasopharynx that makes the procedure of taking a nasopharyngeal swab impossible
- Children with chronic infectious (chronic otitis media or chronic sinusitis prior to study inclusion.
- Received any pneumococcal vaccine in the past.
- Children who have already provided a NP sample in the same study period.
- Any relevant hemorrhagic disorder.
- Any febrile process (fever ≥ 38°C) at time of screening.
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
3641 Patients enrolled
Trial Details
Trial ID
NCT00952367
Start Date
April 1 2009
End Date
March 1 2010
Last Update
April 23 2012
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Beijing, Beijing Municipality, China, 10013
2
Pfizer Investigational Site
Dongguan, Guangdong, China, 523016
3
Pfizer Investigational Site
Wuhan, Hubei, China, 430015
4
Pfizer Investigational Site
Nanjing, Jiangsu, China, 210003